Scott Yung Ho Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Scott Yung Ho Kim has a total of 173 co-authors. Here are the top co-authors by number of shared publications:
- David Gibbes Miller
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
6 shared publications - Raymond De Vries
University of Michigan
5 shared publications - Trudo Lemmens
University of Toronto
5 shared publications Alexander Ruck Keene
239 Essex Chambers, London, UK
4 shared publications- James H. Flory
Department of Population Health Sciences, Weill Cornell Medicine , New York, NY 10065 , USA
4 shared publications - Andrew Julian Vickers
Department of Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Center New York NY USA
3 shared publications
Latest Publications
- 23 October 2026
- Published by Taylor & Francis in The American Journal of Bioethics
- p. 1-14
What Is a Terminal Disease? Hidden Expansion of Medically Assisted Death in the United States
Fourteen of the world’s 195 countries currently permit some form of euthanasia or assisted suicide, usually involving medical professionals, i.e., medically assisted death (MAD). A subset of these ...
- 23 October 2026
- Published by Taylor & Francis in The American Journal of Bioethics
- p. 1-14
What Is a Terminal Disease? Hidden Expansion of Medically Assisted Death in the United States
Fourteen of the world’s 195 countries currently permit some form of euthanasia or assisted suicide, usually involving medical professionals, i.e., medically assisted death (MAD). A subset of these ...
- 25 September 2026
- Published by Taylor & Francis in The New Bioethics
- p. 1-15
Autonomy as the sole justification for assisted death?
I. Assisted death (euthanasia and/or assisted suicide, EAS) regimes take a variety of forms. The US states that permit EAS limit the practice to persons with a terminal illness, and Australian stat...
- 25 September 2026
- Published by Taylor & Francis in The New Bioethics
- p. 1-15
Autonomy as the sole justification for assisted death?
I. Assisted death (euthanasia and/or assisted suicide, EAS) regimes take a variety of forms. The US states that permit EAS limit the practice to persons with a terminal illness, and Australian stat...
- Open Access
- 5 August 2026
- Published by Elsevier in SSRN Electronic Journal
"The Case Against Legalizing Assisted Death for Psychiatric Disorders"
This chapter examines whether euthanasia and assisted suicide for psychiatric disorders (pEAS) should be legalized. While proponents often rely on parity arguments, claiming that psychiatric suffering should be treated the same as physical suffering in jurisdictions that permit assisted dying, we argue that such conceptual ethical reasoning is insufficient to justify legalization. Legalization requires careful policy analysis that considers empirical evidence, implementation challenges, and broader societal consequences. Using Canada’s planned expansion of Medical Assistance in Dying (MAID) for mental illness as a case study, and drawing on developments in Belgium and the Netherlands, we analyze concerns related to the scale of pEAS, the difficulty of reliably assessing irremediability and decision-making capacity, the risk of premature and preventable deaths, and the impact on vulnerable populations. We further examine effects on stigma, suicide prevention, mental health care, and the integrity of medicine. We conclude that the current evidence does not support the claim that pEAS can be implemented safely and reliably, and that its legalization risks serious long-term harms for individuals, mental health care systems, and society. Therefore, pEAS should not be legalized.
- 5 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open Access"The Case Against Legalizing Assisted Death for Psychiatric Disorders"
This chapter examines whether euthanasia and assisted suicide for psychiatric disorders (pEAS) should be legalized. While proponents often rely on parity arguments, claiming that psychiatric suffering should be treated the same as physical suffering in jurisdictions that permit assisted dying, we argue that such conceptual ethical reasoning is insufficient to justify legalization. Legalization requires careful policy analysis that considers empirical evidence, implementation challenges, and broader societal consequences. Using Canada’s planned expansion of Medical Assistance in Dying (MAID) for mental illness as a case study, and drawing on developments in Belgium and the Netherlands, we analyze concerns related to the scale of pEAS, the difficulty of reliably assessing irremediability and decision-making capacity, the risk of premature and preventable deaths, and the impact on vulnerable populations. We further examine effects on stigma, suicide prevention, mental health care, and the integrity of medicine. We conclude that the current evidence does not support the claim that pEAS can be implemented safely and reliably, and that its legalization risks serious long-term harms for individuals, mental health care systems, and society. Therefore, pEAS should not be legalized.
- 3 April 2026
- Published by Taylor & Francis in AJOB Empirical Bioethics
- Vol. 17 (2) , 85-93
Canadian Medical Assistance in Dying (MAID) and Access to Resources: An Analysis of Media Reports
Following the legalization of medical assistance in dying (MAID) in Canada in 2016, the expansion of eligibility criteria in 2021 permits MAID for both individuals whose death is reasonably foresee...
- 3 April 2026
- Published by Taylor & Francis in AJOB Empirical Bioethics
- Vol. 17 (2) , 85-93
Canadian Medical Assistance in Dying (MAID) and Access to Resources: An Analysis of Media Reports
Following the legalization of medical assistance in dying (MAID) in Canada in 2016, the expansion of eligibility criteria in 2021 permits MAID for both individuals whose death is reasonably foresee...
- Open Access
- 9 January 2026
- Published by Elsevier in Clinical Parkinsonism & Related Disorders
- Vol. 14
Explore thyself: is it time for metacognition screening in clinical trials?
- 9 January 2026
- Published by Elsevier in Clinical Parkinsonism & Related Disorders
- Vol. 14
Open AccessExplore thyself: is it time for metacognition screening in clinical trials?
- Open Access
- 17 September 2025
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 25 (12) , 1-6
Canadian MAID Reform: Response to Peer Commentaries from Holland et al., Downar et al., Peters and Others
- 17 September 2025
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 25 (12) , 1-6
Open AccessCanadian MAID Reform: Response to Peer Commentaries from Holland et al., Downar et al., Peters and Others
- 22 August 2025
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 228, 112428
Bedtime sliding scale insulin is unnecessary for hospitalized patients with bedtime glucose < 300 mg/dL: A nudge-based quasi-experiment
- 22 August 2025
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 228, 112428
Bedtime sliding scale insulin is unnecessary for hospitalized patients with bedtime glucose < 300 mg/dL: A nudge-based quasi-experiment
- 8 August 2025
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 39 (4) , 313-314
Dementia Intervention Trials and Opportunity Costs for Potential Participants
- 8 August 2025
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 39 (4) , 313-314
Dementia Intervention Trials and Opportunity Costs for Potential Participants
- Top Cited PapersOpen Access
- 10 January 2025
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 25 (5) , 6-25
Canadian Medical Assistance in Dying: Provider Concentration, Policy Capture, and Need for Reform
Canada's rapid rise in deaths from euthanasia and physician assisted suicide, termed Medical Assistance in Dying (MAID) in the country, now ranks it second only to the Netherlands in terms of MAiD deaths as percentage of overall deaths, with one province already hosting the highest rate of all jurisdictions in the world. Analyzing Health Canada's annual MAID reports, which show that up to 336 out of 1837 providers are likely responsible for the majority of MAID deaths in a given year, we discuss how the rapid increase likely reflects not a broad Canadian consensus but the capture of a policy-making and implementation process by a small group of activists and clinicians colonizing medicine to become an ideologically driven vehicle for expanding MAID access and delivery. As a remedy and to reprioritize patient safety and protection against premature death, a more transparent, relevant, and safeguarded compliance regime based on evidence-based, multi-perspective policy-making is needed.
- 10 January 2025
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 25 (5) , 6-25
Top Cited PapersOpen AccessCanadian Medical Assistance in Dying: Provider Concentration, Policy Capture, and Need for Reform
Canada's rapid rise in deaths from euthanasia and physician assisted suicide, termed Medical Assistance in Dying (MAID) in the country, now ranks it second only to the Netherlands in terms of MAiD deaths as percentage of overall deaths, with one province already hosting the highest rate of all jurisdictions in the world. Analyzing Health Canada's annual MAID reports, which show that up to 336 out of 1837 providers are likely responsible for the majority of MAID deaths in a given year, we discuss how the rapid increase likely reflects not a broad Canadian consensus but the capture of a policy-making and implementation process by a small group of activists and clinicians colonizing medicine to become an ideologically driven vehicle for expanding MAID access and delivery. As a remedy and to reprioritize patient safety and protection against premature death, a more transparent, relevant, and safeguarded compliance regime based on evidence-based, multi-perspective policy-making is needed.
- 26 November 2024
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 33 (4) , 438-449
Do Caregivers Value the New Antiamyloid Treatments for Alzheimer's Disease More Than Home-Based Care?
- 26 November 2024
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 33 (4) , 438-449
Do Caregivers Value the New Antiamyloid Treatments for Alzheimer's Disease More Than Home-Based Care?